T Sugimoto

766 total citations
32 papers, 590 citations indexed

About

T Sugimoto is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, T Sugimoto has authored 32 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Epidemiology. Recurrent topics in T Sugimoto's work include Hepatitis B Virus Studies (3 papers), Cancer-related Molecular Pathways (3 papers) and Acute Myeloid Leukemia Research (3 papers). T Sugimoto is often cited by papers focused on Hepatitis B Virus Studies (3 papers), Cancer-related Molecular Pathways (3 papers) and Acute Myeloid Leukemia Research (3 papers). T Sugimoto collaborates with scholars based in Japan and United States. T Sugimoto's co-authors include Jun Ishihara, Akio Murai, Ryosei Sakai, Yasufumi Furuhata, Yasushi Noguchi, Qingwei Zhang, Mitsuo Takahashi, Takeshi Kimura, Masato Mori and Hiroshi Hirai and has published in prestigious journals such as American Journal of Clinical Nutrition, Journal of Neurology Neurosurgery & Psychiatry and Tetrahedron.

In The Last Decade

T Sugimoto

30 papers receiving 569 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
T Sugimoto 237 172 68 59 56 32 590
Peter C. Jocelyn 234 1.0× 65 0.4× 39 0.6× 5 0.1× 9 0.2× 8 493
Janette Bobáľová 373 1.6× 33 0.2× 141 2.1× 5 0.1× 28 0.5× 49 742
A Jíndra 168 0.7× 36 0.2× 62 0.9× 5 0.1× 29 0.5× 61 564
Emanuela Lafavia 420 1.8× 29 0.2× 39 0.6× 7 0.1× 10 0.2× 7 779
R.W. McGilvery 411 1.7× 41 0.2× 30 0.4× 5 0.1× 21 0.4× 13 746
A N Dohadwalla 249 1.1× 90 0.5× 44 0.6× 3 0.1× 18 0.3× 24 570
Yousra Abdel–Mottaleb 424 1.8× 36 0.2× 51 0.8× 62 1.1× 10 0.2× 30 706
Jenny Felth 190 0.8× 32 0.2× 66 1.0× 5 0.1× 52 0.9× 12 415
Masaki Ohtawa 233 1.0× 253 1.5× 19 0.3× 7 0.1× 52 0.9× 41 592
J. E. Logan 167 0.7× 44 0.3× 28 0.4× 4 0.1× 7 0.1× 54 589

Countries citing papers authored by T Sugimoto

Since Specialization
Citations

This map shows the geographic impact of T Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Sugimoto more than expected).

Fields of papers citing papers by T Sugimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Sugimoto. The network helps show where T Sugimoto may publish in the future.

Co-authorship network of co-authors of T Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of T Sugimoto. A scholar is included among the top collaborators of T Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Sugimoto. T Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichikawa, K., Satoshi Ito, Emi H. Kato, et al.. (2023). TAS0612, a Novel RSK, AKT, and S6K Inhibitor, Exhibits Antitumor Effects in Preclinical Tumor Models. Molecular Cancer Therapeutics. 23(2). 174–186. 4 indexed citations
2.
Miura, Akihiro, Hiroshi Sootome, Naoya Fujita, et al.. (2021). TAS-119, a novel selective Aurora A and TRK inhibitor, exhibits antitumor efficacy in preclinical models with deregulated activation of the Myc, β-Catenin, and TRK pathways. Investigational New Drugs. 39(3). 724–735. 13 indexed citations
5.
Satô, Yoshiyuki, T Sugimoto, Kaori Kamijo, et al.. (2009). Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(16). 4673–4678. 46 indexed citations
6.
Komatsu, Setsuko, T Sugimoto, Tomoki Hoshino, Yohei Nanjo, & Kiyoshi Furukawa. (2009). Identification of flooding stress responsible cascades in root and hypocotyl of soybean using proteome analysis. Amino Acids. 38(3). 729–738. 50 indexed citations
7.
Kawanishi, Nobuhiko, et al.. (2006). Structure-based drug design of a highly potent CDK1,2,4,6 inhibitor with novel macrocyclic quinoxalin-2-one structure. Bioorganic & Medicinal Chemistry Letters. 16(19). 5122–5126. 74 indexed citations
8.
Zhang, Qiang, Mami Takahashi, Yoshinori Noguchi, et al.. (2006). Plasma amino acid profiles applied for diagnosis of advanced liver fibrosis in patients with chronic hepatitis C infection. Hepatology Research. 34(3). 170–177. 46 indexed citations
9.
Noguchi, Yasushi, Qingwei Zhang, T Sugimoto, et al.. (2006). Network analysis of plasma and tissue amino acids and the generation of an amino index for potential diagnostic use. American Journal of Clinical Nutrition. 83(2). 513S–519S. 131 indexed citations
10.
Matano, Sadaya, et al.. (2000). Leukemic hypopyon in acute myelogenous leukemia. Annals of Hematology. 79(8). 455–458. 17 indexed citations
11.
Watanabe, Takaho, et al.. (1999). Chiral separation and quantitation of pentazocine enantiomers in pharmaceuticals by capillary zone electrophoresis using maltodextrins. Journal of Pharmaceutical and Biomedical Analysis. 21(1). 75–81. 22 indexed citations
12.
Sugimoto, T, Jun Ishihara, & Akio Murai. (1999). Synthesis of the B,C,D,E,F-Ring Fragment of Pinnatoxins. Synlett. 1999(5). 541–544. 22 indexed citations
13.
Sugimoto, T, et al.. (1998). [Giant platelet-like cell fragments produced from abnormal promyelocytes in acute myelogenous leukemia].. PubMed. 46(2). 182–5. 2 indexed citations
14.
Sugimoto, T, et al.. (1997). Changes in cerebral blood flow and vasoreactivity in response to acetazolamide in patients with transient global amnesia. Journal of Neurology Neurosurgery & Psychiatry. 63(5). 605–610. 21 indexed citations
15.
Ishihara, Jun, T Sugimoto, & Akio Murai. (1997). Asymmetric total synthesis of syringolide 1, a nonproteinaceous elicitor. Tetrahedron. 53(47). 16029–16040. 14 indexed citations
16.
Shiozaki, T., Mitsuo Ohnishi, Osamu Tasaki, et al.. (1995). Low oxygen extraction despite high oxygen delivery causes low oxygen consumption in patients with burns recovering slowly from operative hypothermia. Surgery. 118(1). 44–48. 7 indexed citations
17.
Tsuzuki, H., et al.. (1995). [A case of an intrapulmonary lymph node indistinguishable from carcinoma of the lung by CT].. PubMed. 48(3). 239–41. 1 indexed citations
18.
Fujisawa, Tamotsu, T Sugimoto, & Makoto Shimizu. (1994). Highly stereocontrolled access to trifluoromethylbenzylic alcohols possessing p-substituents by the bakers' yeast reduction. Tetrahedron Asymmetry. 5(6). 1095–1098. 12 indexed citations
19.
Kuwagata, Yasuyuki, et al.. (1991). Hemodynamic response with passive neck flexion in brain death. Neurosurgery. 29(2). 239–239. 10 indexed citations
20.
Amano, Keiko, et al.. (1986). [Diabetic cardiomyopathy in mild diabetics: evaluation by thallium-201 scintigraphy and exercise radionuclide ventriculography].. PubMed. 16(4). 907–17. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026